Location: Home
  • search
  • go
  • Relate News
  • 7/10/2007Speculations Surface about WuXi PharmaTech Possible IPO
  • 7/9/2007China Targets Bribe Takers, But What About Givers? (External)
  • 7/8/2007Top Personnel Change at RDPAC
  • 7/7/2007SFDA Suspends Sales of Methotrexate
  • 7/6/2007More Former Drug Regulators Sentenced to Death and Prison Terms
  • 7/6/2007Fosun Raises $1.5 Billion in Share Sale
  • 7/6/2007Upcoming Event: Effective Cross-cultural Communication for Chinese Emp...
  • 7/6/2007Upcoming Event: Effective Cross-cultural Communication for MNC Expatri...
  • 7/6/2007Interview with Head of ChiMed - Modern Path for TCM (External)
  • 7/5/2007China Sets Up Community Health Association
  • 7/4/2007Hisun to Build Alpharma's Vancomycin Production Facility in Taizhou
  • 7/4/2007Shanghai Cracks Down on Commercial Briberies in Hospitals
  • 7/4/200718 Chinese Artemisinin Producers Bash Novartis for Its "Failure t...
  • 7/4/2007China to Further Modernize Traditional Chinese Medicine
  • 7/4/2007Ten Leading Beijing Pharma Firms Seek to Voice Their Opinions on Healt...
  • 7/4/2007Upcoming Event: BioProcess International Asia Pacific
  • 7/3/2007Northeast Pharma Negatively Affected by Reduced Export Tax Rebates
  • 7/3/2007GSK to Spend US$40 Million in R&D in China
  • 7/3/2007The 8th Healthcare Reform Proposal Gains Popularity As More Proposals ...
  • 7/2/2007Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004...
  • 7/2/2007Safety and Efficacy of TCM Injections Upheld by Chinese Physicians
  • 7/2/2007Trials of Urban Resident Basic Insurance Programs to Begin Soon
  • 6/29/2007Chen Zhu Appointed China's New Health Minister
  • 6/29/2007Local Expert Predict Consolidation in the Chinese Vaccine Industry
  • 6/29/2007AstraZeneca to Purchase US$100 Million Annually from China by 2010
  • 6/29/2007SFDA Strengthens Surveillance of Narcotics and Psychotropics
  • 6/29/2007Millions of Active Chinese Epileptic Patients Fail to Receive Proper T...
  • 6/29/2007China Plans Fast Growth for Its Biotech Industry
  • 6/29/2007CRG Consolidates Five Assets of Beijing Pharma into Beijing Double Cra...
  • 6/27/2007Low R&D Investment and Weak IPR Hinders Growth of China's Biotech ...
  • Page:764/806 Total number of articles:24174: [First][<<] [762] [763] [764] [765] [766] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group